Eli Lilly has announced that it will be acquiring Verve Therapeutics in a deal worth approximately $1.3bn, marking a ...

The US Food and Drug Administration (FDA) has unveiled a new programme that will reduce its review time for certain drug ...

For years, women have been significantly underrepresented in clinical trials, despite making up a large portion of patients ...

AstraZeneca (AZ) has announced promising results from a late-stage study of its C5 complement inhibitor Ultomiris ...

In 2025, data protection is more important than ever. Yet, many in the pharma industry are still behind when it comes to ...

In today’s fast-paced experience economy, pharma companies can no longer rely on static displays and outdated engagement ...